MARKET

APUS

APUS

APIMEDS PHARMACEUTICALS US INC
AMEX
1.620
+0.160
+10.96%
Closed 15:59 02/06 EST
OPEN
1.500
PREV CLOSE
1.460
HIGH
1.710
LOW
1.445
VOLUME
74.06K
TURNOVER
--
52 WEEK HIGH
4.031
52 WEEK LOW
1.370
MARKET CAP
20.37M
P/E (TTM)
-3.4026
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at APUS last week (0202-0206)?
Weekly Report · 1h ago
Weekly Report: what happened at APUS last week (0126-0130)?
Weekly Report · 02/02 09:42
Weekly Report: what happened at APUS last week (0119-0123)?
Weekly Report · 01/26 09:42
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 01/22 21:05
Weekly Report: what happened at APUS last week (0112-0116)?
Weekly Report · 01/19 09:46
Weekly Report: what happened at APUS last week (0105-0109)?
Weekly Report · 01/12 09:44
Weekly Report: what happened at APUS last week (1229-0102)?
Weekly Report · 01/05 09:42
Apimeds Pharmaceuticals Reshapes Board After Director Removal
TipRanks · 01/02 22:00
More
About APUS
Apimeds Pharmaceuticals US, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing Apitox, an intradermally administered bee venom-based toxin. It is focused on developing Apitox in the treatment of inflammatory conditions in the United States, specifically osteoarthritis and multiple sclerosis. Its subsidiary, MindWave Innovations Inc, is a provider of institutional digital asset treasury (DAT) solutions.

Webull offers Apimeds Pharmaceuticals US, Inc. stock information, including AMEX: APUS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APUS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading APUS stock methods without spending real money on the virtual paper trading platform.